对以醇为基础的胺酸类似物作为基因素脱乙酶 (HDACs) 抑制剂的综合性审查
Deepali Shukla1, Balaji Wamanrao Matore1, Anjali Murmu1
1Laboratory of Drug Discovery and Ecotoxicology, Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India.
Future medicinal chemistry
|December 22, 2025
概括
基于醇的胺酸衍生物显示出作为癌症治疗中的素脱乙酶抑制剂 (HDACIs) 的前景. 结构性修改提高了它们的效力和选择性,有助于开发下一代抗癌药物.
科学领域:
- 药用化学 医学化学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药物发现 药物发现 药物发现
背景情况:
- 基因组脱乙酶 (HDAC) 是表观遗传酶,对于染色质重塑和基因转录至关重要.
- 异常的HDAC活性与癌症的进展有关,包括瘤发生,血管生成,转移和对治疗的抗性.
研究的目的:
- 系统地调查醇基酸 (ABHA) 衍生物的设计,机制和结构-活性关系 (SAR).
- 为了评估ABHA作为抗癌应用的潜在基因素脱乙酶抑制剂 (HDACI).
主要方法:
- 从2008年到2025年进行的系统文献综述.
- 对针对HDAC的各种ABHA衍生品的SAR分析.
- 对药物动力学特性和异构体选择性的评估.
主要成果:
- 包含异环基架的ABHA (例如1,3,4-oxadiazole,pyrazole,imidazole,triazole,indazole,thiadiazole) 具有显著的结合亲和力.
- 替代剂,结合剂和协调位点的结构变化调节HDAC异型选择性和细胞毒性作用.
- 优化的ABHA显示出增强的药理动力学和强大的酶抑制.
结论:
- 基于醇的胺酸混合物为开发新型的异形选择性HDACI提供了多功能支架.
- 这些化合物对抗癌症药物设计具有显著的治疗前景.
- 进一步的合理开发可以导致下一代HDACI具有更高的功效.
相关概念视频
02:32Histone Modification
15.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.8K
02:32Histone Modification
4.3K
4.3K
02:25Spreading of Chromatin Modifications
9.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.3K
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
895
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
895
01:30Enzyme Inhibition
91.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.2K
02:30Histone Variants at the Centromere
4.9K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.9K